BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25953703)

  • 1. In Vitro, Ex Vivo, and In Vivo Determination of Thyroid Hormone Modulating Activity of Benzothiazoles.
    Hornung MW; Kosian PA; Haselman JT; Korte JJ; Challis K; Macherla C; Nevalainen E; Degitz SJ
    Toxicol Sci; 2015 Aug; 146(2):254-64. PubMed ID: 25953703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How the Xenopus eleutheroembryonic thyroid assay compares to the amphibian metamorphosis assay for detecting thyroid active chemicals.
    Du Pasquier D; Salinier B; Coady KK; Jones A; Körner O; LaRocca J; Lemkine G; Robin-Duchesne B; Weltje L; Wheeler JR; Lagadic L
    Regul Toxicol Pharmacol; 2024 May; 149():105619. PubMed ID: 38614220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening.
    Deisenroth C; Soldatow VY; Ford J; Stewart W; Brinkman C; LeCluyse EL; MacMillan DK; Thomas RS
    Toxicol Sci; 2020 Mar; 174(1):63-78. PubMed ID: 31808822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin-Binding Activity of Complex Mixtures Representing the Composition of Thyroid-Hormone Disrupting Contaminants in House Dust and Human Serum.
    Hamers T; Kortenkamp A; Scholze M; Molenaar D; Cenijn PH; Weiss JM
    Environ Health Perspect; 2020 Jan; 128(1):17015. PubMed ID: 32003587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid disrupting chemicals and developmental neurotoxicity - New tools and approaches to evaluate hormone action.
    O'Shaughnessy KL; Gilbert ME
    Mol Cell Endocrinol; 2020 Dec; 518():110663. PubMed ID: 31760043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping action of T
    Tribondeau A; Du Pasquier D; Benchouaia M; Blugeon C; Buisine N; Sachs LM
    Front Endocrinol (Lausanne); 2024; 15():1360188. PubMed ID: 38529399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-Throughput in vitro Data, High-Throughput Exposure Modeling, and Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.
    Leonard JA; Tan YM; Gilbert M; Isaacs K; El-Masri H
    Toxicol Sci; 2016 May; 151(1):57-70. PubMed ID: 26865668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental endocrine disruptors and amphibian immunity: A bridge between the thyroid hormone axis and T cell development.
    McGuire CC; Robert JR
    Dev Comp Immunol; 2023 Mar; 140():104617. PubMed ID: 36529309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
    Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
    Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals-The ATHENA Project.
    Kortenkamp A; Axelstad M; Baig AH; Bergman Å; Bornehag CG; Cenijn P; Christiansen S; Demeneix B; Derakhshan A; Fini JB; Frädrich C; Hamers T; Hellwig L; Köhrle J; Korevaar TIM; Lindberg J; Martin O; Meima ME; Mergenthaler P; Nikolov N; Du Pasquier D; Peeters RP; Platzack B; Ramhøj L; Remaud S; Renko K; Scholze M; Stachelscheid H; Svingen T; Wagenaars F; Wedebye EB; Zoeller RT
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and experimental validation of 3D QSAR models for the screening of thyroid peroxidase inhibitors using integrated methods of computational chemistry.
    Rudresh BB; Tater AK; Barot V; Patel N; Desai A; Mitra S; Deshpande A
    Heliyon; 2024 Apr; 10(8):e29756. PubMed ID: 38660252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo investigation of a thyroid hormone system-specific interaction with triazoles.
    Kadic A; Oles P; Fischer BC; Reetz AE; Sylla BS; Feiertag K; Ritz V; Heise T; Marx-Stoelting P; Tralau T; Renko K; Solano MLM
    Sci Rep; 2024 Mar; 14(1):6503. PubMed ID: 38499550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ubiquitous tire rubber additive induced serious eye injury in zebrafish (Danio rerio).
    Chang J; Huang R; Zhang Z; Pan Y; Ma Z; Wan B; Wang H
    J Hazard Mater; 2024 Jul; 472():134461. PubMed ID: 38696959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro screening of per- and polyfluorinated substances (PFAS) for interference with seven thyroid hormone system targets across nine assays.
    Degitz SJ; Olker JH; Denny JS; Degoey PP; Hartig PC; Cardon MC; Eytcheson SA; Haselman JT; Mayasich SA; Hornung MW
    Toxicol In Vitro; 2024 Mar; 95():105762. PubMed ID: 38072180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
    He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
    Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross species extrapolation of the disruption of thyroid hormone synthesis by oxyfluorfen using in vitro data, physiologically based pharmacokinetic (PBPK), and thyroid hormone kinetics models.
    Decrane R; Stoker T; Murr A; Ford J; El-Masri H
    Curr Res Toxicol; 2023; 5():100138. PubMed ID: 38074188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of thyroid peroxidase inhibition by chemical exposure: comparison of cell models and detection methods.
    Liu R; Novák J; Hilscherová K
    Arch Toxicol; 2024 May; ():. PubMed ID: 38796608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical evaluation and standardization of the human thyroid microtissue assay.
    Foley B; Hopperstad K; Gamble J; Lynn SG; Thomas RS; Deisenroth C
    Toxicol Sci; 2024 Apr; 199(1):89-107. PubMed ID: 38310358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico bioavailability triggers applied to direct and indirect thyroid hormone disruptors.
    Kühne R; Hilscherová K; Smutna M; Leßmöllmann F; Schüürmann G
    Chemosphere; 2024 Jan; 348():140611. PubMed ID: 37972869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Evaluation System for Post-Metabolic Activity of Potential Thyroid-Disrupting Chemicals.
    Jang Y; Moon JH; Jeon BK; Park HJ; Lee HJ; Lee DY
    J Microbiol Biotechnol; 2023 Oct; 33(10):1351-1360. PubMed ID: 37415082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.